Electromed doubles on marketing clearance for new SmartVest model

Shares of Electromed (ELMD +110.9%) are on their way to a banner session on the heels of FDA marketing clearance for SmartVest SQL.

The SQL is "smaller, quieter, and lighter" than previous versions, the company notes.

ELMD says the device should be available in the U.S. "within the next 60 days." (PR)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs